Who Owns Siemens Healthineers?

Siemens Healthineers operates under a sustainability framework focused on three pillars: Healthcare Access, Resource Preservation, and Diverse and Engaged Healthineers.

Healthcare Access: The company runs global partnerships to improve healthcare access in underserved communities. In Colombia, nearly 200,000 women have benefited from breast cancer initiatives, with 73% of women with suspected breast cancer able to access biopsies as of October 2024. In 2025, new breast cancer programs were launched in Kumasi, Ghana, and Tbilisi, Georgia.

Resource Preservation: Siemens Healthineers achieved half of its sustainability targets ahead of schedule by fiscal 2024. The company focuses on reducing environmental impact across operations and supply chain, including energy efficiency in manufacturing and product lifecycle management.

Diversity and Inclusion: The company aims to increase the proportion of women in senior management positions to 26%. As of FY2023, 25% of senior management positions were held by women.

Environmental Compliance: Beginning FY2025, Siemens Healthineers' sustainability reporting complies with the EU's Corporate Sustainability Reporting Directive (CSRD) and European Sustainability Reporting Standards (ESRS).

• Frost & Sullivan 2025 Company of the Year Award: Received the 2025 North America Company of the Year Award for Excellence in Advanced Visualization Applications
• Berkeley Haas Best Case Award 2025: Received for its digital transformation journey case study
• Siemens Inventor of the Year 2024: Thirteen inventors recognized, with AI playing a role in over half of the winning solutions
• DAX Inclusion: Siemens Healthineers is included in the DAX index of Germany's 40 largest publicly traded companies
• Sustainability Leadership: Achieved half of sustainability targets ahead of schedule by FY2024

Magnetom MRI Class 1 Recall (October 2025): The US FDA announced a Class 1 recall affecting nine types of Siemens Healthineers MRI systems from the Magnetom series. The recall was prompted by an error message related to magnet supervision and heater power above the alarm threshold. Siemens notified consignees on August 28, 2025, instructing customers not to reboot affected systems but to contact Siemens Customer Service Organization. Class 1 is the FDA's most serious recall type, indicating potential for serious injury or death.

3 Tesla MRI Systems Correction: The FDA issued a safety alert regarding Siemens Healthineers' correction for 3 Tesla MRI systems, addressing potential issues with the magnet supervision system that could lead to overheating.

Varian Integration Challenges: Following the $16.4 billion acquisition of Varian in 2021, Siemens Healthineers faced integration challenges combining two large organizations with different cultures and product portfolios.

Diagnostics Transformation: The Diagnostics segment has undergone a multi-year transformation program involving restructuring and cost reductions, which has included workforce adjustments and facility consolidations.

China Market Volatility: The Diagnostics segment has faced revenue challenges in China due to centralized volume-based public procurement policies that have depressed pricing.